rheumatology & Musculoskeltal

---

NIHR Portfolio Studies - open to recruitment:

BSRBR: Toxicity from Biological Therapy
Principal Investigator: Dawn Collier
​Sponsor: University of Manchester
The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.
​

IMID BioResource
Principal Investigator: Tara Lees
Sponsor: Manchester University NHS Foundation Trust
Working with the NIHRBR we are proposing a centralised national recallable bioresource of 16,000 patients and relatives of patients with one of more of a spectrum of disorders which comprise immune-mediated inflammatory diseases (IMIDs) to support scientific and clinical IMID research. 

---